Pharmacokinetics of Novel Plant Cell-Expressed Taliglucerase Alfa in Adult and Pediatric Patients with Gaucher Disease

Taliglucerase alfa is a beta-glucocerebrosidase enzyme replacement therapy approved in the United States, Israel, and other countries for treatment of Type 1 Gaucher disease in adults, and is the first approved plant cell—expressed recombinant protein. In this report, taliglucerase alfa pharmacokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas, Richat, Park, Glen, Damle, Bharat, Chertkoff, Raul, Alon, Sari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459956/
https://www.ncbi.nlm.nih.gov/pubmed/26053270
http://dx.doi.org/10.1371/journal.pone.0128986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459956/
https://www.ncbi.nlm.nih.gov/pubmed/26053270
http://dx.doi.org/10.1371/journal.pone.0128986

Ejemplares similares